109 related articles for article (PubMed ID: 35790266)
1. Comparative Analysis of the Antitumor Immune Profiles of Paired Radiotherapy-naive and Radiotherapy-treated Cervical Cancer Tissues.
Imamura A; Oike T; Sato H; Yoshimoto Y; Ando K; Ohno T
Anticancer Res; 2022 Jul; 42(7):3341-3348. PubMed ID: 35790266
[TBL] [Abstract][Full Text] [Related]
2. Genetic variations in cytotoxic T-lymphocyte antigen-4 and susceptibility to cervical cancer.
Xiong YH; He L; Fei J
Int Immunopharmacol; 2014 Jan; 18(1):71-6. PubMed ID: 24201079
[TBL] [Abstract][Full Text] [Related]
3. Gene expression changes in residual advanced cervical cancer after radiotherapy: indicators of poor prognosis and radioresistance?
Fu ZC; Wang FM; Cai JM
Med Sci Monit; 2015 May; 21():1276-87. PubMed ID: 25940978
[TBL] [Abstract][Full Text] [Related]
4. Association between cancer immunity and treatment results in uterine cervical cancer patients treated with radiotherapy.
Someya M; Tsuchiya T; Fukushima Y; Hasegawa T; Takada Y; Hori M; Miura K; Kitagawa M; Gocho T; Hirohashi Y; Torigoe T; Iwasaki M; Matsuura M; Saito T; Sakata KI
Jpn J Clin Oncol; 2020 Oct; 50(11):1290-1297. PubMed ID: 33089868
[TBL] [Abstract][Full Text] [Related]
5. Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929).
Da Silva DM; Enserro DM; Mayadev JS; Skeate JG; Matsuo K; Pham HQ; Lankes HA; Moxley KM; Ghamande SA; Lin YG; Schilder RJ; Birrer MJ; Kast WM
Clin Cancer Res; 2020 Nov; 26(21):5621-5630. PubMed ID: 32816895
[TBL] [Abstract][Full Text] [Related]
6. Elevation of microRNA-512-5p inhibits MUC1 to reduce radioresistance in cervical cancer.
Zhang J; Wang L; Jiang J; Qiao Z
Cell Cycle; 2020 Mar; 19(6):652-665. PubMed ID: 32126879
[TBL] [Abstract][Full Text] [Related]
7. Increased Expression of Cytotoxic T-Lymphocyte-Associated Protein 4 by T Cells, Induced by B7 in Sera, Reduces Adaptive Immunity in Patients With Acute Liver Failure.
Khamri W; Abeles RD; Hou TZ; Anderson AE; El-Masry A; Triantafyllou E; Bernsmeier C; Larsen FS; Singanayagam A; Kudo N; Possamai LA; Lebosse F; Auzinger G; Bernal W; Willars C; Weston CJ; Lombardi G; Wendon J; Thursz M; Antoniades CG
Gastroenterology; 2017 Jul; 153(1):263-276.e8. PubMed ID: 28363639
[TBL] [Abstract][Full Text] [Related]
8. The association between cytotoxic T lymphocyte-associated antigen-4 and cervical cancer.
Liu P; Xu L; Sun Y; Wang Z
Tumour Biol; 2014 Apr; 35(4):2893-903. PubMed ID: 24317815
[TBL] [Abstract][Full Text] [Related]
9. Searching for pathogenic gene functions to cervical cancer.
Ahn WS; Bae SM; Lee JM; Namkoong SE; Han SJ; Cho YL; Nam GH; Seo JS; Kim CK; Kim YW
Gynecol Oncol; 2004 Apr; 93(1):41-8. PubMed ID: 15047212
[TBL] [Abstract][Full Text] [Related]
10. Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma.
Wagener-Ryczek S; Schoemmel M; Kraemer M; Bruns C; Schroeder W; Zander T; Gebauer F; Alakus H; Merkelbach-Bruse S; Buettner R; Loeser H; Thelen M; Schlößer HA; Quaas A
Cancer Immunol Immunother; 2020 Apr; 69(4):523-533. PubMed ID: 31960110
[TBL] [Abstract][Full Text] [Related]
11. Analysis of promoter methylation, polymorphism and expression profile of cytotoxic T-lymphocyte-associated antigen-4 in patients with gastric cancer.
Kordi-Tamandani DM; Davani SK; Baranzehi T; Hemati S
J Gastrointestin Liver Dis; 2014 Sep; 23(3):249-53. PubMed ID: 25267951
[TBL] [Abstract][Full Text] [Related]
12. Clinical Implications of Aberrant PD-1 and CTLA4 Expression for Cancer Immunity and Prognosis: A Pan-Cancer Study.
Liu JN; Kong XS; Huang T; Wang R; Li W; Chen QF
Front Immunol; 2020; 11():2048. PubMed ID: 33072070
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T‑lymphocyte-associated antigen‑4 polymorphisms and susceptibility to cervical cancer: a meta‑analysis.
Qiu H; Tang W; Yin P; Cheng F; Wang L
Mol Med Rep; 2013 Dec; 8(6):1785-94. PubMed ID: 24126947
[TBL] [Abstract][Full Text] [Related]
14. [Association between CTLA-4 gene polymorphism and susceptibility to cervical cancer].
Li H; Zhou YF; Guo HY; Sun T; Zhang WH; Lin DX
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):681-4. PubMed ID: 22340049
[TBL] [Abstract][Full Text] [Related]
15. Microarray analysis of DNA damage repair gene expression profiles in cervical cancer cells radioresistant to 252Cf neutron and X-rays.
Qing Y; Yang XQ; Zhong ZY; Lei X; Xie JY; Li MX; Xiang DB; Li ZP; Yang ZZ; Wang G; Wang D
BMC Cancer; 2010 Feb; 10():71. PubMed ID: 20184742
[TBL] [Abstract][Full Text] [Related]
16. Regulation of cytotoxic T lymphocyte antigen 4 by cyclic AMP.
Li J; Lin KW; Murray F; Nakajima T; Zhao Y; Perkins DL; Finn PW
Am J Respir Cell Mol Biol; 2013 Jan; 48(1):63-70. PubMed ID: 23024062
[TBL] [Abstract][Full Text] [Related]
17. Single-cell RNA-sequencing reveals radiochemotherapy-induced innate immune activation and MHC-II upregulation in cervical cancer.
Liu C; Li X; Huang Q; Zhang M; Lei T; Wang F; Zou W; Huang R; Hu X; Wang C; Zhang X; Sun B; Xing L; Yue J; Yu J
Signal Transduct Target Ther; 2023 Jan; 8(1):44. PubMed ID: 36710358
[TBL] [Abstract][Full Text] [Related]
18. Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicity.
Pai CS; Simons DM; Lu X; Evans M; Wei J; Wang YH; Chen M; Huang J; Park C; Chang A; Wang J; Westmoreland S; Beam C; Banach D; Bowley D; Dong F; Seagal J; Ritacco W; Richardson PL; Mitra S; Lynch G; Bousquet P; Mankovich J; Kingsbury G; Fong L
J Clin Invest; 2019 Jan; 129(1):349-363. PubMed ID: 30530991
[TBL] [Abstract][Full Text] [Related]
19. Suppressor of cytokine signaling (SOCS) genes are silenced by DNA hypermethylation and histone deacetylation and regulate response to radiotherapy in cervical cancer cells.
Kim MH; Kim MS; Kim W; Kang MA; Cacalano NA; Kang SB; Shin YJ; Jeong JH
PLoS One; 2015; 10(4):e0123133. PubMed ID: 25849377
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in cytotoxic T-lymphocyte associated antigen 4 gene does not affect scytotoxic T-lymphocyte associated antigen 4 levels in human papillomavirus-infected women with or without cervical cancer.
Wagh P; Kulkarni P; Kerkar S; Warke H; Chaudhari H; Deodhar K; Rekhi B; Tongaonkar H; Mania-Pramanik J
Indian J Med Microbiol; 2018; 36(2):207-210. PubMed ID: 30084412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
